PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

A Year of Transformation for Science & Medicine

Targeting KOLs with Data

Lessons Learned from the Multichannel Shakeout

Advertisement
Top Story
Tax Overhaul: A Plus for Pharma
By enacting landmark tax reform legislation that makes major changes in the corporate tax structure, Congress this week delivered a significant Christmas present to President Trump — and to industry, writes Jill Wechsler
/Read more/
Advertisement
Free White Paper: Customer Experience in Pharma with UCB, Teva and Pfizer.
5 case studies from industry leaders on how they are exceeding customers expectations and creating "wow" moments.
Learn more
Regulatory
America's Opioid Crisis: Potential Increased Marketing Regulation
With over 70 companies manufacturing immediate-release opioids in the United States, federal regulators may look to limit marketing as a strategy to reduce the prescription and over-prescription of opioids
/Read more/
Advertisement
New Video Series! COMMERCIAL INSIGHTS into DIGITAL TRENDS
In this video series, produced in partnership with Veeva Systems, Pharmaceutical Executive speaks with biopharma and industry experts about the future of life sciences commercial capabilities and the hottest trends affecting this important market segment. Filmed live at the 9th Annual Veeva Systems' Global Commercial and Medical Summit.
Learn more
Patient Adherence
The Reluctant Customer: Using Personas to Improve Compliance
Consumers of life sciences products are reluctant customers, and this reluctance can turn into non-compliance. Organizations and providers need to understand patients at a human level, and what will motivate them to stay with a treatment plan, writes John Pagliuca
/Read more/
Advertisement
Survey: Artificial Intelligence in the Pharma Industry
Pharmaceutical Executive is conducting a brief survey on behalf of one of our partners to gather insights on Artificial Intelligence. Please take a moment to create this short survey and you will receive a $10 Starbucks gift card.
Take Our Survey Now
Calendar
/ January 23–24, 2018: 13th Biosimilars Summit /
Alexandria, VA
/ January 24–25, 2018: Reimbursement and Contracting /
Philadelphia, PA
/ February 27–28, 2018: Speaker Programs 2018 /
Philadelphia, PA
/ March 25–28, 2018: 14th Annual Pharma Forum /
Philadelphia, PA
/ March 28–29, 2018: Expanded Access Programs /
Washington, DC
/ April 10–12, 2018: LogiPharma 2018 /
Montreux, Switzerland
/ April 11–12, 2018: 8th Annual Global Transparency Reporting Congress /
London, UK
/ May 10–11, 2018: Pharma Marketing Summit /
Palm Beach, FL
/ October 15–17, 2018: 28th Annual Sharing Conference: Compliance /
National Harbor, MD
Advertisement
Pharma Pricing & Market Access Congress 2018
20-21 March 2018 Business Design Centre
Learn more
Europe
Is Brexit Really Top of Pharma’s New Year “To-Do” List?
For the pharma sector across Europe, Brexit is just one of the tough issues to think about in 2018, writes Reflector
/Read more/
Advertisement
GDPR: Implications for the global Life Sciences industry
On Demand
Learn more
Industry update
// Spectrum Pharmaceuticals (Irvine, CA) dismissed chief executive officer Rajesh C. Shrotriya on Sunday. Joseph W. Turgeon, the current company president and chief operating officer, was named the new CEO. Thomas J. Riga, takes on the COO position, and Stuart M. Krassner becomes chairman of the board. // Greg Perry joined the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA, Geneva, Switzerland) as new Assistant Director General. // Atlas Genetics (Cambridge, MA and Bath, UK) announced the appointment of industry veteran Marc Jones as Chief Operating Officer and Chief Financial Officer. // SCORR Marketing (Kearney, NE) promoted several members of its team, including April Roggasch to chief financial officer and Kate Covalt to senior program manager.
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com